3650 results for «444»

Filter By

3650 results

Closing remarks - PCR Innovators Day 2019

20 May 2019 – From PCR Innovators Day 2019

Consult this session to discover the closing remarks on PCR Innovators Day 2019, regarding the presentations of innovative technologies: Cavis Technologies' WireCath, CorFlow Therapeutics, Procerion and GENOSS.

Closing remarks - PCR

EAPCI General Assembly

22 May 2019 – From EuroPCR 2019

Consult this session to discover the EAPCI General Assembly's slides, presented during EuroPCR 2019. Learn more about the different committees and the grants programme.

EAPCI General Assembly

TAVI for aortic valve-in-valve - LIVE Case

22 May 2019 – From EuroPCR 2019

Consult this session to discover an exciting case, live transmitted during EuroPCR 2019: it will take you to a whole new territory of TAVI, focusing on the generation of bioprosthetic heart valves issues and the transcatheter solutions which are emerging as an optimal approach to this...

TAVI for aortic valve-in-valve

Treatment of bending zones in femoral and popliteal arteries - LIVE Case

23 May 2019 – From EuroPCR 2019

Consult this session to learn more about the different characteristics of devices and treatment strategies including: directional atherectomy + drug-coated balloon, calcified plaque softening with lithoplasty, new stents conforming to anatomy, and more!

LIVE demonstration from Clinique Pasteur - Toulouse, France

Treatment of bending

Impella percutaneous ventricular assist device malrotation in social media: a call to action

20 Apr 2023

The data from this study suggest that, from a SoMe perspective, correct Impella orientation is often overlooked, and that Impella malrotation is a common issue in real-world clinical practice, potentially associated with relevant complications. 

Alessandro Beneduce

Author

Alessandro Beneduce
Luca Baldetti

Author

Luca Baldetti

Author

Anna Mara Scandroglio
Mamas Mamas

Author

Mamas Mamas
Alaide Chieffo

Author

Alaide Chieffo
Impella pVAD Malrotation in social media

The FLAVOUR Randomized Clinical Trial: Comparison of Fractional Flow Reserve-guided and Intravascular Ultrasound-guided Percutaneous Coronary Intervention in Intermediate Coronary Artery Stenosis

22 Mar 2022

Daniele Giacoppo analyses the main results of the FLAVOUR trial which were presented by Bon-Kwon Koo, from Seoul National University Hospital, South Korea at the American College of Cardiology 2022. 

Daniele Giacoppo

Author

Daniele Giacoppo
The FLAVOUR Randomized Clinical Trial: Comparison of Fractional Flow Reserve-guided and Intravascular Ultrasound-guided Percutaneous Coronary Intervention in Intermediate Coronary Artery Stenosis

Elixir Medical completes enrollment in BIOADAPTOR randomized controlled trial of Dynamx Coronary Bioadaptor System

15 Feb 2022

OPTION – Indobufen or aspirin on top of clopidogrel after coronary drug-eluting stent implantation

08 Nov 2022

Ali Nazmi Calik provides his take on OPTION, which was presented during AHA 2022 in Chicago.

Ali Nazmi Calik

Author

Ali Nazmi Calik
OPTION – Indobufen or aspirin on top of clopidogrel after coronary drug-eluting stent implantation

New insights from the early and delayed aortic valve replacement implant patients: a sub-analysis of the Early TAVR trial

29 Mar 2025

Luigi Biasco provides his take on a sub-analysis of the Early TAVR trial about the early and delayed aortic valve replacement implant patients presented by Philippe Genereux at ACC.25 in Chicago.

Luigi Biasco

Author

Luigi Biasco
New insights from the early and delayed aortic valve replacement implant patients: a sub-analysis of the Early TAVR trial

The effectiveness and safety of a planned investment procedure in high-risk chronic total occlusions - The INVEST CTO single arm study

03 Nov 2025

Kalaivani Mahadevan and Sofia Papadopoulou provide their take on the INVEST CTO trial, presented by Anja Oksnes at TCT 2025, in San Francisco.

Kalaivani Mahadevan

Author

Kalaivani Mahadevan
Sofia Papadopoulou

Author

Sofia Papadopoulou
INVEST-CTO: Single arm study of a planned investment procedure in high-risk CTO PCI
Didn’t find what you were looking for?